Revive Therapeutics Ltd C.RVV

Upon further review... My F u MF and F u RVV stands!

[Trippedstocks]

so, 2 people have completed the trial? Prove me wrong!

[Chrisxd5]

Only 2 common for real? 

[Towser7]

Not sure where that number 2 came from, but MF needs to do a PR on timing.  If it's going to be another 30-45 days or whatever, then give us that.   I think going past the half way point and then again after the 2/1 date with no news is poor.   

[Trippedstocks]

read the prospectus. Particularly: Recent Developments, Bucillamine pg 6-7 , and Business Objectives and Milestones chart pg. 26 . How many patients do we have enrolled? Could be 2, 3, 4, what does their "on pace" mean?

[1ottrunner]

The prospectus clearly says that 200 patients will complete the trial by the end of the second quarter 2021, so just 4 months from now.

[Cashuniversity]

You sound like a complete moron. Perhaps reread the documents, it's clear that 200 patients will be put through the program and with 2 sites opening after Jan 20th to even joke that there's only a handful of people in the program is braindead. The end goal is 1000 and by all accounts this team will execute. Imbecile.

[Trippedstocks]

from page 7 The Company has committed to over ten clinical sites, which to date include sites in Florida, Texas, Nevada, North Carolina and California, and it is estimated that over 200 patients will have completed the study for the interim analysis by the end of the second quarter of 2021. The interim analysis will determine the better performing Bucillamine dose arm for the remainder of the

[Trippedstocks]

and according to page 26, we will have to spend an additional $2,000,000 from the bought deal in Q1 on the 210 interm analysis. And $4,000,000 for the 400 in Q2-2021. So I figured we may have 100 people enrolled maybe more. I don't know. Do I need to explain my reasoning further?

[Trippedstocks]

but it could be financial quarters ;) good luck!